Literature DB >> 31278533

S100B and its association with HIV-associated neurocognitive disorders.

Nath Limpruttidham1,2, Brooks I Mitchell3, Kalpana J Kallianpur3, Beau K Nakamoto3,4, Scott A Souza3,5, Bruce Shiramizu3, Lishomwa C Ndhlovu3,6, Dominic C Chow3, Cecilia M Shikuma3.   

Abstract

Entities:  

Year:  2019        PMID： 31278533     DOI： 10.1007/s13365-019-00773-8

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


× No keyword cloud information.
  6 in total

1.  Updated research nosology for HIV-associated neurocognitive disorders.

Authors:  A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

Review 2.  Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis.

Authors:  Eric Mercier; Amélie Boutin; François Lauzier; Dean A Fergusson; Jean-François Simard; Ryan Zarychanski; Lynne Moore; Lauralyn A McIntyre; Patrick Archambault; François Lamontagne; France Légaré; Edward Randell; Linda Nadeau; François Rousseau; Alexis F Turgeon
Journal:  BMJ       Date:  2013-04-04

3.  Oxidative mitochondrial DNA damage in peripheral blood mononuclear cells is associated with reduced volumes of hippocampus and subcortical gray matter in chronically HIV-infected patients.

Authors:  Kalpana J Kallianpur; Mariana Gerschenson; Brooks I Mitchell; Daniel E LiButti; Tracie M Umaki; Lishomwa C Ndhlovu; Beau K Nakamoto; Dominic C Chow; Cecilia M Shikuma
Journal:  Mitochondrion       Date:  2016-02-23       Impact factor: 4.160

4.  Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

Authors:  E R Peskind; W S Griffin; K T Akama; M A Raskind; L J Van Eldik
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

5.  Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.

Authors:  Ned Sacktor; David R Boulware; Mahsa Abassi; Bozena M Morawski; Gertrude Nakigozi; Noeline Nakasujja; Xiangrong Kong; David B Meya; Kevin Robertson; Ronald Gray; Maria J Wawer
Journal:  J Neurovirol       Date:  2016-12-19       Impact factor: 2.643

6.  Frailty Characteristics in Chronic HIV Patients are Markers of White Matter Atrophy Independently of Age and Depressive Symptoms: A Pilot Study.

Authors:  Kalpana J Kallianpur; Marissa Sakoda; Louie Mar A Gangcuangco; Lishomwa C Ndhlovu; Tracie Umaki; Dominic Chow; Suwarat Wongjittraporn; Cecilia M Shikuma
Journal:  Open Med J       Date:  2016-08-29
  6 in total
  2 in total

Review 1.  Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy.

Authors:  Michellie Thurman; Samuel Johnson; Arpan Acharya; Suresh Pallikkuth; Mohan Mahesh; Siddappa N Byrareddy
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

2.  Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19.

Authors:  Jude Savarraj; Eun S Park; Gabriela D Colpo; Sarah N Hinds; Diego Morales; Hilda Ahnstedt; Atzhiry S Paz; Andres Assing; Fudong Liu; Shivanki Juneja; Eunhee Kim; Sung-Min Cho; Aaron M Gusdon; Pramod Dash; Louise D McCullough; H Alex Choi
Journal:  J Neuroinflammation       Date:  2021-11-27       Impact factor: 8.322
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.